Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAGT is a leading European agricultural biotechnology group specializing in the research, production, and marketing of seeds for major field crops. Headquartered in Rodez, France, the company operates a sophisticated research division, RAGT 2n, which utilizes advanced genomic selection and molecular marker technologies to develop high-performing varieties of wheat, corn, sunflower, and rapeseed. RAGT is recognized as one of the top seed producers in Europe, maintaining a vast portfolio of proprietary varieties tailored to diverse climatic conditions and agricultural needs. The group's activities span the entire value chain, from fundamental genetic research to global commercial distribution. Through strategic partnerships, such as its major collaboration with Bayer in wheat breeding, RAGT continues to drive innovation in crop science to address global food security and sustainable farming challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAGT.